Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Immunogenicity and Safety of Four Different Dosing Regimens of Anthrax Vaccine Adsorbed for Post-Exposure Prophylaxis for Anthrax in Adults
09/2014
Bernstein, D.I., Jackson, L., Patel, S.M., Sahly, H.M., Spearman, P., Rouphael, N., Jr., T.L.Rudge, Hill, H., Goll, J.B.
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial
10/2014
Belshe, R.B., Frey, S.E., Graham, I.L., Anderson, E.L., Jackson, L.A., Spearman, P., Edupuganti, S., Mulligan, M.J., Rouphael, N., Winokur, P., Dolor, R.J., Woods, C.W., Walter, E.B., Chen, W.H., Turley, C., Edwards, K.M., Creech, C.B., Hill, H., Bellamy, A.R.
Impact of a Genomic Classifier of Metastatic Risk on Post Prostatectomy Treatment Recommendations by Radiation Oncologists and Urologists
09/2014
Nguyen, P.L., Shin, H., Yousefi, K., Thompson, D.J., Hornberger, J., Hyatt, A.S., Badani, K.K., Morgan, T., Feng, F.Y.
Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults
10/2014
Callahan, S.T., Wolff, M., Hill, H.R., Edwards, K.M., Vaccine, N.I.A.I.D., Group, T.Evaluation
Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naive T Cells from Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201
08/2014
Waller, E.K., Logan, B.R., Harris, W.A., Devine, S.M., Porter, D.L., Mineishi, S., McCarty, J.M., Gonzalez, C.E., Spitzer, T.R., Krijanovski, O.I., Linenberger, M.L., Woolfrey, A., Howard, A., Wu, J., Confer, D.L., Anasetti, C.
Islet Product Characteristics and Factors Related to Successful Human Islet Transplantation From the Collaborative Islet Transplant Registry (CITR) 1999-2010
11/2014
Balamurugan, A., Naziruddin, B., Lockridge, A., Tiwari, M., Loganathan, G., Takita, M., Matsumoto, S., Papas, K., Trieger, M., Rainis, H., Kin, T., Kay, T., Wease, S., Messinger, S., , , Maffi, P., Secchi, A., Berney, T., O'Connell, P., Hering, B., Barton, F.B.
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies
10/2014
Eapen, M., O'Donnell, P., Brunstein, C.G., Wu, J., Barowski, K., Mendizabal, A., Fuchs, E.J.
Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care In Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome*
10/2014
Saber, W., Le Rademacher, J., Sekeres, M., Logan, B., Lewis, M., Mendizabal, A., Leifer, E., Appelbaum, F.R., Horowitz, M.M., Nakamura, R., Cutler, C.S.
Myelodysplastic Syndromes in the United States: An Update for Clinicians
08/2014
Troy, J.D., Atallah, E., Geyer, J.T., Saber, W.